Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults

Amit Saha1, Kershaw V Patel2, Colby Ayers1

  • 1Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

Insights

Among Black adults, rising levels of high-sensitivity cardiac troponin I (hs-cTnI) indicate increased heart failure risk. Persistent or worsening hs-cTnI elevation is linked to a greater chance of developing heart failure.

Area of Science:

  • Cardiology
  • Biomarkers
  • Public Health

Background:

  • High-sensitivity cardiac troponin I (hs-cTnI) is linked to heart failure (HF) risk in Black adults.
  • Longitudinal changes in hs-cTnI and their association with incident HF, HFrEF, and HFpEF in this population are not well-established.

Purpose of the Study:

  • To investigate the association between longitudinal changes in hs-cTnI levels and the risk of incident heart failure among Black adults.
  • To examine the relationship between hs-cTnI changes and specific HF subtypes (HFrEF and HFpEF).

Main Methods:

  • The study analyzed data from 2423 Black participants in the Jackson Heart Study with hs-cTnI measurements at two visits.
  • Cox models assessed the association of hs-cTnI change categories (incident elevation, stable/improved, worsened) with incident HF risk.
  • Follow-up averaged 12.0 years, during which 139 HF hospitalizations occurred.

Main Results:

  • 11.6% of participants showed incident hs-cTnI elevation, 16.9% had stable/improved elevation, and 4.0% had worsened elevation.
  • Compared to no elevation, incident, stable/improved, and worsened hs-cTnI elevation were associated with significantly higher HF risk (aHR 3.20, 2.40, and 8.10, respectively).
  • Similar associations were observed for both HFrEF and HFpEF risk.

Conclusions:

  • In Black adults, an increase in hs-cTnI levels over time is associated with an elevated risk of developing heart failure.
  • Persistent or worsening subclinical myocardial injury, indicated by hs-cTnI, is a significant predictor of future HF events.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
357
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
256
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
82
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
229
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
27
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K